東軟教育(09616.HK)與大連高新區簽署合作意向框架協議
東軟教育(09616.HK)表示,大連高新區與公司簽署了合作意向框架協議,其中雙方將聚焦元宇宙前沿領域,落地教育科技元宇宙的研發和人才培養,共同打造數字技術發展產學研生態體系。
東軟教育董事長劉積仁在會上展示了東軟教育科技集團兩款新產品,生命與健康元宇宙科普雲展館及元宇宙醫療數字人解剖實驗室。
東軟教育生命與健康元宇宙科普雲展館,是健康醫療科普領域國內首創的元宇宙應用產品,基於醫療健康大數據、人工智能和區塊鏈技術的數智化展館,用戶可通過專業、沉浸、遊戲化的互動體驗,探訪人體世界,面向社會實現元宇宙形態的開放式科普傳播。
東軟教育元宇宙醫療數字人解剖實驗室是基於人體CT和MRI數據,利用人工智能將數字人技術與人體解剖教學有機結合的數字孿生實驗室,用戶可以進行沉浸式的教與學,多角度、多層次、全方位學習人體解剖知識,實現真實標本不能帶來的臨場體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.